Andere Sprachen Lepu Biopharma Co., Ltd.

Aktien

A3DEUE

CNE100004SM4

2157

Markt geschlossen - Hong Kong S.E. Andere Börsenplätze 10:08:49 06.05.2024			% 5 Tage	% 1. Jan.
5,7 ^HKD	-11,08 %		-1,72 %	+35,39 %

12.04.	Keymed Biosciences bringt Medikament für solide Tumore mit erster Patientenstudie voran	MT
27.03.	Lepu Biopharma Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Keymed Biosciences Advances Solid Tumors Drug With First Patient Study	12.04.
Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
Lepu Biopharma's Pancreatic Cancer Drug Gets US FDA Fast-Track Designation	11.03.
Lepu Biopharma Co., Ltd. Receives Fast Track Designation by the Food and Drug Administration of the United States for the Treatment of Pancreatic Cancer	11.03.
Lepu Biopharma Shareholders to Vote Jan. 31 on Contract to Produce Drugs for Lepu Medical Technology	17.01.
Lepu Biopharma Co., Ltd. Announces Completion of Patient Enrollment of Pivotal Phase IIb Clinical Trial for MRG003 for the Treatment of R/M NPC	28.12.
Lepu Biopharma Completes Patient Enrollment for Phase 2B Trial for Nasopharyngeal Cancer Drug	29.12.
Lepu Biopharma Renews Procurement Agreement With Lepu Medical Technology	26.12.
Lepu Biopharma Gets US FDA's Orphan Drug Designation for Pancreatic Cancer Drug	14.12.
Lepu Biopharma Co., Ltd. Announces Orphan-Drug Designation Granted by the FDA to MRG004A for the Treatment of Pancreatic Cancer	14.12.
US FDA Grants Fast Track Designation to Lepu Biopharma's Anti-Cancer Drug	04.12.
Lepu Biopharma to Provide Drug Production Services to Lepu Medical Technology	14.11.
Lepu Biopharma Divests 15% Stake in Technical Services Provider	29.09.23
China Medical System Holdings Limited entered into the equity transfer agreement to acquire 15% stake in Hangzhou HealSun Biopharm Co., Ltd. from Lepu Biopharma Co., Ltd. for approximately CNY 130 million.	29.09.23
Lepu Biopharma Co., Ltd.(SEHK:2157) added to S&P Global BMI Index	18.09.23
Lepu Biopharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	25.08.23
Lepu Biopharma Seeks to Extend Validity of Secondary Listing in Shanghai	09.08.23
Stocks add to rebound; SSE ups earnings guidance	30.03.23
AstraZeneca Completes KYM Solid Tumors Treatment Deal	30.03.23
Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17.03.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Lepu Biopharma Co., Ltd.

Aktien

A3DEUE

CNE100004SM4

2157

Andere Sprachen

Filter